30–50 Dose as in normal renal function10–30 Dose as in normal renal function. Use with caution
<10           : Dose as in normal renal function. Use with caution
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in GFR <10 mL/min
HD                     :Unlikely dialysability. Dose as in GFR <10 mL/min
HDF/high flux   :Unlikely to be dialysed. Dose as in GFR <10 mL/min
CAV/VVHD      :Unlikely dialysability. Dose as in GFR 10 to 20 mL/min
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Antipsychotics: antagonism of anti- Parkinsonian effect – avoid concomitant useMetoclopramide: antagonism of anti- Parkinsonian effect – avoid concomitant useOestrogens and progestogens: concentration increased
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
–
OTHER INFORMATION
If administered with L-dopa, decrease the dose of L-dopa by 20%Take with meals to improve GI tolerance, but Cmax increases by 2.6 hoursNo data in renal impairment Ropinirole is hepatically metabolised to inactive metabolitesFor use in restless legs syndrome in CKD 5, start with a low dose and increase according to tolerability.